Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases
Disease Category: Cystic Fibrosis
Trial Information
Study of an investigational treatment for patients with Cystic Fibrosis
The purpose of this study is to test the safety and effectiveness of an investigational drug for the treatment of patients with Cystic Fibrosis. The study will last for about 1 year. During the study, you will come to the clinic for up to 10 visits and will be contacted by telephone at least 7 times to see how you feel.
Patient Inclusion Criteria: Patients with Cystic Fibrosis (CF) lung disease and FEV1 ≥ 75% but ≤ 110% predicted normal.
Patient Exclusion Criteria: Patient must not be pregnant, have had a prior lung or liver transplant, have had a Chest x-ray with abnormalities suggesting clinically significant active pulmonary disease other than CF
Elaine Kucera, Director, Clinical Research Services
St. Alexius Medical Center
810 E. Rosser Ave., Suite 202
Bismarck, ND 58501
Phone: 701-530-6950
Fax: 701-530-6970
EMail: ekucera@primecare.org
View Google Map
Research Center Information: St. Alexius Medical Center
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
